HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rigid gas-permeable contact lenses for myopia control: effects of discontinuation of lens wear.

Abstract
Conventionally fitted Paraperm O2plus contact lenses were worn for 44 months by 23 myopic children, who discontinued lens wear for 2.5 months and then resumed lens wear with Fluoroperm 30 lenses for a period of 8 months. Mean changes in myopia were: (1) an increase of 0.76 D during the initial 44 months of lens wear, (2) a further increase of 0.27 D during the 2.5 months when lenses were not worn, and (3) a decrease of 0.02 D during the 8-month period of Fluoroperm 30 lens wear. These results show that the effect of rigid gas-permeable lenses on myopia progression is diminished if lens wear is discontinued; however, the mean increase in myopia for these children was significantly less than would have been expected if glasses had been worn for the entire 54.5-month period. The results after discontinuation and then resumption of lens wear show that the effect of contact lenses in controlling the progression of myopia could not be accounted for entirely on the basis of corneal flattening as measured by the keratometer, therefore reinforcing the conclusion that corneal flattening due to rigid lens wear takes place primarily at the corneal apex, rather than in the zone of the cornea measured by the keratometer.
AuthorsT Grosvenor, D Perrigin, J Perrigin, S Quintero
JournalOptometry and vision science : official publication of the American Academy of Optometry (Optom Vis Sci) Vol. 68 Issue 5 Pg. 385-9 (May 1991) ISSN: 1040-5488 [Print] United States
PMID1852402 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Child
  • Contact Lenses
  • Humans
  • Myopia (physiopathology, prevention & control)
  • Refraction, Ocular
  • Refractive Errors (prevention & control)
  • Reproducibility of Results
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: